Following the end of the government shutdown, Republicans and Democrats are discussing health care policy changes, including the potential extension of COVID-19-era tax credits. Last night, President ...
Major health care policy changes under the Trump administration have driven some professional medical organizations to take different approaches to their advocacy strategies.During President Donald J.
Time has run out for lawmakers to extend the enhanced Obamacare subsidies before they expire at year’s end, putting Republicans on the hot seat with health care policy as they gear up for the midterms ...
As the nation's attention turns to Capitol Hill, a pivotal health care policy debate is poised to unfold, potentially offering more affordable insurance options. With health care costs at the ...
The ML Strategies 2026 Policy Outlook Series explores the policy, political, and regulatory dynamics shaping key sectors in the year ahead. Across six installments, our team analyzes how federal ...
The prospect of soaring health care costs could exacerbate Americans’ feelings about affordability, an issue that President Trump has tried to downplay. But Democrats plan to keep the issue front and ...
Health care policy will be top of mind when Congress returns to Washington in January, with lawmakers acknowledging that escalating insurance premiums are hitting millions of Americans. That’s about ...
The White House has postponed its rollout of a new proposal to address health care costs aimed at averting a spike in premiums driven by the expiration of key Affordable Care Act subsidies, a White ...
President Donald Trump hasn’t officially unveiled his new health care plan. But plenty in his party already oppose it. The White House on Monday delayed its proposal for averting a spike in Affordable ...
Alex Garlick worked in Congress during the 2017 debate over whether to repeal the Affordable Care Act (ACA), which was one of the most memorable years for federal healthcare policy in recent memory.
Robert Applebaum does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...